Status:

RECRUITING

Open, Non-comparative Pilot Study to Evaluate the Safety and Efficacy of Intraovarian Plasma Rich in Growth Factors (PRGF) in Patients With Low Ovarian Reserve

Lead Sponsor:

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Conditions:

Low Ovarian Reserve

Eligibility:

FEMALE

18-50 years

Phase:

NA

Brief Summary

The use of plasma rich in growth factors (PRGF) improves ovarian reserve markers and IVF laboratory parameters in women with low ovarian reserve. Primary objective To compare ovarian reserve markers ...

Eligibility Criteria

Inclusion

  • Women of childbearing age as defined by the CTFG\*.
  • Women in group 3 and 4 of the POSEIDON classification for low reserve:
  • POSEIDON 3: patients ˂ 35 years of age with decreased ovarian reserve (AMH \<1.2 ng/ml, AFC \<5).
  • POSEIDON 4: patients ≥ 35 years with decreased ovarian reserve (AMH \<1.2 ng/ml, AFC \<5).
  • Patients with at least one ovary.
  • Infertility of more than 1 year duration.
  • Provision of safe ovarian access on the day of the puncture.
  • They agree to participate and to give their written consent.

Exclusion

  • Have a diagnosis of clinical ovarian insufficiency - Patients with an ongoing pregnancy - Patients with a clinical diagnosis of ovarian failure
  • Patients with ongoing pregnancy
  • Current or previous IgA deficiency,
  • Ovarian failure secondary to identified genetic causes.
  • Presence of pelvic adhesions after abdominal surgery.
  • Chronic use of aspirin, NSAIDs or anticoagulants.
  • Diseases that alter platelet number or function.
  • Psychiatric disorder that precludes participation in the study (including active substance abuse or dependence).
  • Obesity (BMI ≥ 30).
  • Current female smokers (≥ 15 cigarettes per day) - Current smoking (≥ 15 cigarettes per day)
  • Patients affected by neoplastic disease
  • Severe male factor infertility

Key Trial Info

Start Date :

May 30 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2026

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06975683

Start Date

May 30 2025

End Date

May 1 2026

Last Update

June 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Universitario Fundación Jiménez Diaz

Madrid, Spain, 28924